lobbying_activities: 2461804

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2461804	d5656b5c-cf96-4665-9f86-5ef6f35db644	Q2	HOLLAND & KNIGHT LLP	18466	TEVA PHARMACEUTICALS USA, INC.	2020	second_quarter	PHA	Drug pricing; Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074); Families First Coronavirus Response Act (H.R. 6201); Coronavirus Aid, Relief, and Economic Security (CARES) Act (H.R. 748); Global supply chain issues; National Defense Authorization Act.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2020-07-07T13:26:04.840000-04:00